Please login to the form below

Not currently logged in
Email:
Password:

Bispecific antibody

This page shows the latest Bispecific antibody news and features for those working in and with pharma, biotech and healthcare.

Genentech reports positive phase 3 data for its Tecentriq combination in liver cancer

Genentech reports positive phase 3 data for its Tecentriq combination in liver cancer

cancers. In December 2022, its bispecific antibody, Lunsumio (mosunetuzumab-axgb), was approved by the FDA for the treatment of adult patients with relapsed or refractory follicular lymphoma after two or more

Latest news

More from news
Approximately 6 fully matching, plus 61 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 16 partially matching documents found.

Latest appointments

  • New hires at Crescendo, Healx and Galecto New hires at Crescendo, Healx and Galecto

    late phase clinical trials. Before that, he was clinical research physician at Chugai Pharma Europe, where he led clinical development for a bispecific T-cell engaging antibody programme and other early

  • New hires at FibroGen, Saniona and Turbine New hires at FibroGen, Saniona and Turbine

    Previously, she held the position of senior vice president of drug discovery at F-star, overseeing all internal and collaborative bispecific antibody discovery programmes.

  • F-star hires ex-BMS immuno-oncology leader

    Dr Kayitalire’s background will be of benefit to F-star, as it looks to advance its bispecific antibody pipeline in oncology. ... Hewill oversee the clinical development of F-star’s lead product candidate, FS118, a LAG-3/PD-L1-targeting tetravalent

  • F-star appoints GSK's Neil Brewis F-star appoints GSK's Neil Brewis

    Cambridge-based antibody research company F-Star has appointed Dr Neil Brewis as chief scientific officer. ... This appointment strengthens our experienced management team and supports F-star's strategy to lead the bispecific antibody space in

More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Bedrock Healthcare Communications

Bedrock Healthcare Communications is an award-winning, independent agency founded in 2011. We partner with healthcare professionals, patients, and global pharmaceutical...

Latest intelligence

World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
Great Expectations – exploring the counterpoint between advances in oncology and the challenges of ensuring life-changing medicines reach patients...
Strategic behaviour
Strong strategising depends on your colleagues’ behaviour...
Pharmaceutical Marketing Strategies For The Digital Age
In the digital age, a strong digital marketing strategy is crucial for businesses, especially in the highly competitive and complex pharmaceutical industry. There are key trends shaping pharmaceutical marketing, such...